Mangiferin | 1093730-67-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡喃
• 英文名称: Mangiferin
• 英文别名: 1,3,6,7-Tetrahydroxy-2-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]xanthen-9-one
• CAS: 1093730-67-6
• 化学式: C₁₉H₁₈O₁₁
• mdl: MFCD00601812
• 分子量: 422.345
• InChiKey: AEDDIBAIWPIIBD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.4
• 重原子数：
  30
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  197
• 氢给体数：
  8
• 氢受体数：
  11

文献信息

• 20(R)-GINSENOSIDE RG3 POLYACYLATED DERIVATIVES, PREPARATION AND APPLICATION THEREOF
  申请人：FU Li

  公开号：US20170327529A1

  公开（公告）日：2017-11-16

  The present invention provides 20(R)-ginsenoside Rg3 polyacylated derivatives of the formula (I) and preparation method and anti-tumor application thereof: wherein, R═CH 3 (CH 2 )nCO, n=0˜5.

  本发明提供了式(I)的20(R)-人参皂苷Rg3多酰化衍生物及其制备方法和抗肿瘤应用：其中，R═CH3(CH2)nCO，n=0˜5。
• [EN] XANTHONE DERIVATIVES, UV PROTECTIVE COMPOSITION CONCENTRATE, METHOD OF PREPARATION OF UV PROTECTIVE COMPOSITION CONCENTRATE, USE OF UV PROTECTIVE COMPOSITION CONCENTRATE AND COSMETIC UV PROTECTIVE PRODUCT<br/>[FR] DÉRIVÉS DE XANTHONE, CONCENTRÉ DE COMPOSITION DE PROTECTION CONTRE LES UV, PROCÉDÉ DE PRÉPARATION DE CONCENTRÉ DE COMPOSITION DE PROTECTION CONTRE LES UV, UTILISATION D'UN CONCENTRÉ DE COMPOSITION DE PROTECTION CONTRE LES UV ET PRODUIT COSMÉTIQUE DE PROTECTION CONTRE LES UV
  申请人：UNIV JAGIELLONSKI

  公开号：WO2021215943A1

  公开（公告）日：2021-10-28

  The first object of the invention is a xanthone derivative described by formula (I) where R1 is a substituent selected from the group comprising: hydrogen or alkoxy group; R2 is a substituent selected from the group comprising methylcinnamoyl, phenylpenta-2,4- dienenitrile, cyanoethenylphenyl or cyanoethenylalkyl substituent, wherein the phenyl ring is substituted with R3 selected from the group consisting of: hydrogen, alkoxy substituent or halide atom. The second objection of the invention is a UV protective composition concentrate containing the xanthone derivative described by the formula (I). The third object of the invention is a method for the preparation of a UV protective composition concentrate. The next object of the invention is the use of a UV protective composition concentrate for the production of UV protective cosmetic products. Yet another object of the invention is a cosmetic UV protective product.

  该发明的第一个对象是一种黄酮衍生物，其化学式为（I），其中R1是从包括：氢或烷氧基的基团中选择的取代基；R2是从包括：甲基肉桂酰基、苯基戊-2,4-二烯腈基、氰基乙烯基苯基或氰基乙烯基取代基中选择的取代基，其中苯环与R3选择自包括：氢、烷氧基取代基或卤素原子的基团。该发明的第二个对象是一种含有上述化学式（I）所述黄酮衍生物的紫外线防护组合物浓缩物。该发明的第三个对象是一种制备紫外线防护组合物浓缩物的方法。该发明的下一个对象是利用紫外线防护组合物浓缩物生产紫外线防护化妆品产品。该发明的另一个对象是一种化妆用紫外线防护产品。
• [EN] SELECTIVE FOXO INHIBITORS FOR TREATMENT OF DIABETES AND OTHER DISORDERS RELATED TO IMPAIRED PANCREATIC FUNCTION<br/>[FR] INHIBITEURS SÉLECTIFS DE FOXO POUR LE TRAITEMENT DU DIABÈTE ET D'AUTRES TROUBLES LIÉS À UNE FONCTION PANCRÉATIQUE ALTÉRÉE
  申请人：UNIV COLUMBIA

  公开号：WO2020198351A1

  公开（公告）日：2020-10-01

  Various embodiments relate to a compound (represented by Formula I) or a pharmaceutically acceptable salt or tautomer thereof. The compound may selectively inhibit a Forkhead Box O1 (FOXO1) transcription factor. Various embodiments relate to methods comprising administering to a mammal having a disease or disorder associated with impaired pancreatic endocrine function, a therapeutically effective amount of the compound or a pharmaceutically acceptable salt or tautomer thereof. Various embodiments relate to methods for producing enteroendocrine cells that make and secrete insulin in a mammal, comprising administering to the mammal an effective amount of the compound or a pharmaceutically acceptable salt or tautomer thereof.

  各种实施方式涉及一种化合物（由式I表示）或其药用可接受的盐或互变异构体。该化合物可能选择性地抑制Forkhead Box O1（FOXO1）转录因子。各种实施方式涉及方法，包括向患有与胰腺内分泌功能受损相关的疾病或疾病的哺乳动物施用该化合物或其药用可接受的盐或互变异构体的治疗有效量。各种实施方式涉及方法，用于在哺乳动物中产生能够制造和分泌胰岛素的肠内分泌细胞，包括向该哺乳动物施用该化合物或其药用可接受的盐或互变异构体的有效量。
• [EN] BIOACTIVE PHENOLATE IONIC COMPLEXES<br/>[FR] COMPLEXES IONIQUES PHÉNOLATE BIOACTIFS
  申请人：YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD

  公开号：WO2021214762A1

  公开（公告）日：2021-10-28

  The invention provides an isolated material, or a phenolate form of at least one phenol- containing active material, wherein the isolated material comprises one or more phenolate species and a counter ion (a cation) in the form of a metal salt, a phosphonium or an ammonium.

  该发明提供了一种孤立的材料，或者至少一种含酚活性物质的酚酚酚形式，其中该孤立的材料包括一个或多个酚酚酚物种和一个对离子（阳离子）的金属盐、磷酰胺或铵的形式。
• Water Soluble and Activable Phenolics Derivatives with Dermocosmetic and Therapeutic Applications and Process for Preparing Said Derivatives
  申请人：Auriol Daniel

  公开号：US20090233876A1

  公开（公告）日：2009-09-17

  The invention relates to the preparation of phenolics derivatives by enzymatic condensation of phenolics selected among pyrocatechol or its derivatives with the glucose moiety of sucrose. The production of said phenolics derivatives is achieved with a glucosyltransferase (EC 2.4.1.5). These O-α-glucosides of selected phenolics are new, have a solubility in water higher than that of their parent polyphenol and have useful applications in cosmetic and pharmaceutical compositions, such as antioxidative, antiviral, antibacterial, immune-stimulating, antiallergic, antihypertensive, antiischemic, antiarrhythmic, antithrombotic, hypocholesterolemic, antilipoperoxidant, hepatoprotective, anti-inflammatory, anticarcinogenic antimutagenic, antineoplastic, anti-thrombotic, and vasodilatory formulations, or in any other field of application.

  该发明涉及通过酶催化将选择自间苯二酚或其衍生物的酚类与蔗糖的葡萄糖部分进行缩合来制备酚类衍生物。所述酚类衍生物的生产是通过葡萄糖转移酶（EC 2.4.1.5）实现的。所选酚类的这些O-α-葡糖苷是新的，其在水中的溶解度高于它们的原始多酚，并且在化妆品和药用组合物中具有有用的应用，如抗氧化、抗病毒、抗菌、免疫刺激、抗过敏、降压、抗缺血、抗心律失常、抗血栓形成、降胆固醇、抗脂质过氧化、肝脏保护、抗炎症、抗癌变突变、抗肿瘤、抗血栓形成和扩血管等配方，或者在任何其他应用领域中。